abstract |
The present invention describes compounds of formula I (See formula I) that are novel antagonists for melanin concentrating hormone (MCH), as well as methods for preparing said compounds; In another embodiment, the invention describes pharmaceutical compositions comprising such MCH antagonists as well as methods for using them to treat obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes. |